You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永泰生物-B(06978.HK)開始於北京興建新生物藥物研發及產業化基地
格隆匯 06-17 21:22

格隆匯6月17日丨永泰生物-B(06978.HK)公吿,內容有關公司的間接全資附屬公司北京永泰生物製品有限公司與中建三局集團有限公司就建造位於中國北京市北京經濟技術開發區的研發及產業化基地而訂立日期為2021年3月26日的協議。

董事會宣佈,研發及產業化基地建造開工儀式於2021年6月17日上午10時18分舉行,標誌着集團北京研發及產業化基地建設項目的正式啟動。

研發及產業化基地預期將包括多幢用作細胞療法及其他生產車間及質檢的建築物,可讓集團因應集團核心在研產品及其他在研產品的商業化進行必要的研發工作、測試及質量保證程序。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account